Kraenzlin, Marius

The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-β Signaling Pathways

Fukada, T., Civic, N., Furuichi, T., Shimoda, S., Mishima, K., Higashiyama, H., Idaira, Y., Asada, Y., Kitamura, H., Yamasaki, S., et al. (2008) · PLoS ONE

Trace Elements in HealthConnective tissue disorders research

Cited by 287

Spondylocheiro Dysplastic Form of the Ehlers-Danlos Syndrome—An Autosomal-Recessive Entity Caused by Mutations in the Zinc Transporter Gene SLC39A13

Giunta, C., Elçioglu, N. H., Albrecht, B., Eich, G., Chambaz, C., Janecke, A. R., Yeowell, H., Weis, M., Eyre, D. R., Kraenzlin, M., et al. (2008) · The American Journal of Human Genetics

Connective tissue disorders researchDermatological and Skeletal Disorders

Cited by 218

Changes in bone mineral content after surgical treatment of morbid obesity

von Mach, M.-A., Stoeckli, R., Bilz, S., Kraenzlin, M., Langer, I., & Keller, U. (2004) · Metabolism

Bariatric Surgery and OutcomesBone health and osteoporosis research

Cited by 164

Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation

Rohrbach, M., Vandersteen, A., Yiş, U., Serdaroglu, G., Ataman, E., Chopra, M., Garcia, S., Jones, K., Kariminejad, A., Kraenzlin, M., et al. (2011) · Orphanet Journal of Rare Diseases

Connective tissue disorders researchDermatological and Skeletal Disorders

Cited by 106

Use of Depot Medroxyprogesterone Acetate and Fracture Risk

Meier, C., Brauchli, Y. B., Jick, S. S., Kraenzlin, M. E., & Meier, C. R. (2010) · The Journal of Clinical Endocrinology & Metabolism

Bone health and osteoporosis researchReproductive Health and Contraception

Cited by 90

Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial

Meier, C., Beat, M., Guglielmetti, M., Christ-Crain, M., Staub, J.-J., & Kraenzlin, M. (2004) · Osteoporosis International

Thyroid Disorders and TreatmentsBone health and osteoporosis research

Cited by 55

Bone mineral density and its determinants in men with opioid dependence

Gotthardt, F., Huber, C., Thierfelder, C., Grize, L., Kraenzlin, M., Scheidegger, C., & Meier, C. (2017) · Journal of Bone and Mineral Metabolism

Bone health and osteoporosis researchOpioid Use Disorder Treatment

Cited by 55

Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice

Sieber, P., Lardelli, P., Kraenzlin, C. A., Kraenzlin, M. E., & Meier, C. (2013) · Clinical Drug Investigation

Bone health and treatmentsBone health and osteoporosis research

Cited by 49

Patients on injectable diacetylmorphine maintenance have low bone mass: Low BMD in diacetylmorphine patients

DÜRSTELER-MACFARLAND, K. M., KOWALEWSKI, R., BLOCH, N., WIESBECK, G. A., KRAENZLIN, M. E., & STOHLER, R. (2011) · Drug and Alcohol Review

Bone health and osteoporosis researchOpioid Use Disorder Treatment

Cited by 22